Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-11

Clinical Trial Update: Liposome Bupivacaine for ANKLE Blocks [Phase 2]

View source ↗

Summary

Phase 2 trial update on liposome bupivacaine for ankle blocks in hallux valgus (bunions) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liposome bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Catherine Vandepitte, M.D. | Conditions: Hallux Valgus (Bunions) | Phase 2 | Status: COMPLETED